表紙
市場調查報告書

代謝性疾病用醫藥品的全球市場:抗糖尿病藥物·抗甲狀腺藥·其他醫藥品 (副甲狀腺機能亢進症·下垂體功能降低症·腎上腺功能降低症)

Metabolic Disorders Drugs Global Market Report 2019

出版商 The Business Research Company 商品編碼 531331
出版日期 內容資訊 英文 300 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
代謝性疾病用醫藥品的全球市場:抗糖尿病藥物·抗甲狀腺藥·其他醫藥品 (副甲狀腺機能亢進症·下垂體功能降低症·腎上腺功能降低症) Metabolic Disorders Drugs Global Market Report 2019
出版日期: 2019年01月01日內容資訊: 英文 300 Pages
簡介

本報告提供全球代謝性疾病用醫藥品的市場調查,提供市場定義和概要,市場的各種影響因素分析,各藥物部門·各地各國趨勢與市場規模的變化與預測,並彙整與宏觀經濟因素·醫療保健市場全體·各種產業指標的比較,競爭環境,企業簡介等資料。

第1章 市場特徵

第2章 市場規模·成長率

  • 市場成長:迄今的過程
    • 成長推進因素
    • 阻礙成長要素
  • 市場成長:預測
    • 成長推進因素
    • 阻礙成長要素

第3章 大環境分析

第4章 客戶資訊

第5章 代謝性疾病用醫藥品市場分析:各種類

  • 全球市場的實際成果:各種類
    • 抗糖尿病藥物
    • 抗甲狀腺藥
    • 其他
      • 副甲狀腺機能亢進症
      • 下垂體功能降低症
      • 腎上腺功能降低症
  • 全球市場的變化與預測:各種類
  • 市場趨勢·策略

第6章 代謝性疾病用醫藥品市場分析:各地各國分析

  • 全球市場的實際成果:各地區
  • 全球市場的變化與預測:各地區
  • 市場實際成果:各國
  • 市場變化與預測:各國
  • 全球醫藥品市場實際成果:部門·各地區
  • 全球醫藥品市場實際成果:部門·各國

第7章 宏觀經濟因素與市場比較

  • 市場規模的佔 GDP的百分比
  • 平均每個人的平均支出額

第8章 宏觀經濟因素與市場比較:各國

  • 市場規模的佔 GDP的百分比:各國
  • 平均每個人的平均支出額:各國

第9章 產業指標與市場比較

  • 全球藥劑師數:各國
  • 市場收益 vs 藥劑師數:各國
  • 全球醫藥品公司數:各國
  • 市場收益 vs 醫藥品公司數:各國
  • 全球對R&D/產品開發的平均支出額:各國
  • 市場收益 vs 對R&D/產品開發的平均支出額:各國
  • 全球非專利&品牌銷售額的比例:各國
  • 市場收益 vs 非專利&品牌銷售額的比例:各國
  • 高血壓的患病人數:各國
  • 全球一般開業醫生數:各國
  • 市場收益 vs 一般開業醫生數:各國

第10章 亞太地區市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 中國
  • 印度
  • 日本
  • 澳洲

第11章 西歐市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙

第12章 東歐市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 俄羅斯

第13章 北美市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 美國

第14章 南美市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 巴西

第15章 中東市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類

第16章 非洲市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類

第17章 競爭環境

  • 企業簡介
  • Novo Nordisk
  • Sanofi
  • Merck & Co.
  • Eli Lilly
  • Astrazeneca PLC

第18章 主要M&A:代謝性疾病用醫藥品市場

第19章 市場背景:醫藥品市場

第20章 醫藥品產業的Financial Margins

第21章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Metabolic Disorders Drugs Market Global Report 2019 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global metabolic disorders drugs market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the metabolic disorders drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Metabolic Disorders Drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The metabolic disorders drugs market section of the report gives context. It compares the metabolic disorders drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, metabolic disorders drugs indicators comparison.

Scope

Markets Covered: Anti Diabetics drugs, Anti-Thyroid drugs, Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)

Companies Mentioned: Sanofi S.A, Novo Nordisk A/S, AstraZeneca Plc, Johnson & Johnson, Merck & Co

Metrics Covered: Number of Enterprises, Number of Employees

Countries: Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, metabolic disorders drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Metabolic Disorders Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Metabolic Disorders Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Metabolic Disorders Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Metabolic Disorders Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Metabolic Disorders Drugs Market Trends And Strategies

8. Metabolic Disorders Drugs Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
    • 8.2.1. Drivers Of The Market
    • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
    • 8.3.1. Drivers Of The Market
    • 8.3.2. Restraints On The Market

9. Metabolic Disorders Drugs Market Regional Analysis

  • 9.1. Global Metabolic Disorders Drugs Market, 2018, By Region, Value ($ Billion)
  • 9.2. Global Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 9.3. Global Metabolic Disorders Drugs Market, Growth And Market Share Comparison, By Region

10. Metabolic Disorders Drugs Market Segmentation

  • 10.1. Global Metabolic Disorders Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
    • 10.1.1. Anti Diabetics drugs
    • 10.1.2. Anti-Thyroid drugs
    • 10.1.3. Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)

11. Metabolic Disorders Drugs Market Metrics

  • 11.1. Metabolic Disorders Drugs Market Size, Percentage Of GDP, 2014 - 2022, Global
  • 11.2. Per Capita Average Metabolic Disorders Drugs Market Expenditure, 2014 - 2022, Global

12. Asia-Pacific Metabolic Disorders Drugs Market

  • 12.1. Asia-Pacific Metabolic Disorders Drugs Market Overview
  • 12.2. Asia-Pacific, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • 12.3. Asia-Pacific, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 12.4. Asia-Pacific, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 12.5. Asia-Pacific, Metabolic Disorders Drugs Market Metrics
    • 12.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Asia-Pacific Countries
  • 12.6. Asia-Pacific Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 12.7. Asia-Pacific Metabolic Disorders Drugs Market: Country Analysis
    • 12.7.1. China Metabolic Disorders Drugs Market
      • 12.7.1.1. China Metabolic Disorders Drugs Market Overview
      • 12.7.1.2. China Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.1.3. China Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.1.4. China Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.2. Australia Metabolic Disorders Drugs Market
      • 12.7.2.1. Australia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.2.2. Australia Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.2.3. Australia Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.3. Hong Kong Metabolic Disorders Drugs Market
      • 12.7.3.1. Hong Kong Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.4. India Metabolic Disorders Drugs Market
      • 12.7.4.1. India Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.4.2. India Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.4.3. India Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.5. Indonesia Metabolic Disorders Drugs Market
      • 12.7.5.1. Indonesia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.6. Japan Metabolic Disorders Drugs Market
      • 12.7.6.1. Japan Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.6.2. Japan Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.6.3. Japan Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.7. Malaysia Metabolic Disorders Drugs Market
      • 12.7.7.1. Malaysia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.8. New Zealand Metabolic Disorders Drugs Market
      • 12.7.8.1. New Zealand Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.9. Philippines Metabolic Disorders Drugs Market
      • 12.7.9.1. Philippines Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.10. Singapore Metabolic Disorders Drugs Market
      • 12.7.10.1. Singapore Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.11. South Korea Metabolic Disorders Drugs Market
      • 12.7.11.1. South Korea Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.12. Thailand Metabolic Disorders Drugs Market
      • 12.7.12.1. Thailand Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.13. Vietnam Metabolic Disorders Drugs Market
      • 12.7.13.1. Vietnam Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

13. Western Europe Metabolic Disorders Drugs Market

  • 13.1. Western Europe Metabolic Disorders Drugs Market Overview
  • 13.2. Western Europe, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • 13.3. Western Europe, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 13.4. Western Europe, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 13.5. Western Europe, Metabolic Disorders Drugs Market Metrics
    • 13.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Western Europe Countries
  • 13.6. Western Europe Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 13.7. Western Europe Metabolic Disorders Drugs Market: Country Analysis
    • 13.7.1. Austria Metabolic Disorders Drugs Market
      • 13.7.1.1. Austria Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.2. Belgium Metabolic Disorders Drugs Market
      • 13.7.2.1. Belgium Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.3. Denmark Metabolic Disorders Drugs Market
      • 13.7.3.1. Denmark Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.4. Finland Metabolic Disorders Drugs Market
      • 13.7.4.1. Finland Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.5. France Metabolic Disorders Drugs Market
      • 13.7.5.1. France Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.5.2. France Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.5.3. France Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.6. Germany Metabolic Disorders Drugs Market
      • 13.7.6.1. Germany Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.6.2. Germany Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.6.3. Germany Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.7. Ireland Metabolic Disorders Drugs Market
      • 13.7.7.1. Ireland Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.8. Italy Metabolic Disorders Drugs Market
      • 13.7.8.1. Italy Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.8.2. Italy Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.8.3. Italy Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.9. Netherlands Metabolic Disorders Drugs Market
      • 13.7.9.1. Netherlands Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.10. Norway Metabolic Disorders Drugs Market
      • 13.7.10.1. Norway Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.11. Portugal Metabolic Disorders Drugs Market
      • 13.7.11.1. Portugal Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.12. Spain Metabolic Disorders Drugs Market
      • 13.7.12.1. Spain Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.12.2. Spain Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.12.3. Spain Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.13. Sweden Metabolic Disorders Drugs Market
      • 13.7.13.1. Sweden Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.14. Switzerland Metabolic Disorders Drugs Market
      • 13.7.14.1. Switzerland Metabolic Disorders Drugs Market2013 - 2022, Value ($ Billion)
    • 13.7.15. UK Metabolic Disorders Drugs Market
      • 13.7.15.1. UK Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.15.2. UK Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.15.3. UK Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

14. Eastern Europe Metabolic Disorders Drugs Market

  • 14.1. Eastern Europe Metabolic Disorders Drugs Market Overview
  • 14.2. Eastern Europe, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • 14.3. Eastern Europe, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 14.4. Eastern Europe, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 14.5. Eastern Europe, Metabolic Disorders Drugs Market Metrics
    • 14.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Eastern Europe Countries
  • 14.6. Eastern Europe Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 14.7. Eastern Europe Metabolic Disorders Drugs Market: Country Analysis
    • 14.7.1. Czech Republic Metabolic Disorders Drugs Market,
      • 14.7.1.1. Czech Republic Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.2. Poland Metabolic Disorders Drugs Market
      • 14.7.2.1. Poland Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.3. Romania Metabolic Disorders Drugs Market
      • 14.7.3.1. Romania Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.4. Russia Metabolic Disorders Drugs Market
      • 14.7.4.1. Russia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
      • 14.7.4.2. Russia Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
      • 14.7.4.3. Russia Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

15. North America Metabolic Disorders Drugs Market

  • 15.1. North America Metabolic Disorders Drugs Market Overview
  • 15.2. North America, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • 15.3. North America, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 15.4. North America, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 15.5. North America, Metabolic Disorders Drugs Market Metrics
    • 15.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, North America Countries
  • 15.6. North America Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 15.7. North America Metabolic Disorders Drugs Market: Country Analysis
    • 15.7.1. Canada Metabolic Disorders Drugs Market
      • 15.7.1.1. Canada Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 15.7.2. Mexico Metabolic Disorders Drugs Market
      • 15.7.2.1. Mexico Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 15.7.3. USA Metabolic Disorders Drugs Market
      • 15.7.3.1. USA Metabolic Disorders Drugs Market Overview
      • 15.7.3.2. USA Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
      • 15.7.3.3. USA Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
      • 15.7.3.4. USA Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

16. South America Metabolic Disorders Drugs Market

  • 16.1. South America Metabolic Disorders Drugs Market Overview
  • 16.2. South America, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • 16.3. South America, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 16.4. South America, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 16.5. South America, Metabolic Disorders Drugs Market Metrics
    • 16.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, South America Countries
  • 16.6. South America Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 16.7. South America Metabolic Disorders Drugs Market: Country Analysis
    • 16.7.1. Argentina Metabolic Disorders Drugs Market
      • 16.7.1.1. Argentina Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.2. Brazil Metabolic Disorders Drugs Market
      • 16.7.2.1. Brazil Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
      • 16.7.2.2. Brazil Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
      • 16.7.2.3. Brazil Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 16.7.3. Chile Metabolic Disorders Drugs Market
      • 16.7.3.1. Chile Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.4. Colombia Metabolic Disorders Drugs Market
      • 16.7.4.1. Colombia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.5. Peru Metabolic Disorders Drugs Market
      • 16.7.5.1. Peru Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.6. Venezuela Metabolic Disorders Drugs Market
      • 16.7.6.1. Venezuela Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

17. Middle East Metabolic Disorders Drugs Market

  • 17.1. Middle East Metabolic Disorders Drugs Market Overview
  • 17.2. Middle East, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • 17.3. Middle East, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 17.4. Middle East, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 17.5. Middle East, Metabolic Disorders Drugs Market Metrics
    • 17.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Middle East Countries
  • 17.6. Middle East Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 17.7. Middle East Metabolic Disorders Drugs Market: Country Analysis
    • 17.7.1. Saudi Arabia Metabolic Disorders Drugs Market
      • 17.7.1.1. Saudi Arabia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.2. Israel Metabolic Disorders Drugs Market
      • 17.7.2.1. Israel Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.3. Turkey Metabolic Disorders Drugs Market
      • 17.7.3.1. Turkey Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.4. UAE Metabolic Disorders Drugs Market
      • 17.7.4.1. UAE Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

18. Africa Metabolic Disorders Drugs Market

  • 18.1. Africa Metabolic Disorders Drugs Market Overview
  • 18.2. Africa, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • 18.3. Africa, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 18.4. Africa, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 18.5. Africa, Metabolic Disorders Drugs Market Metrics
    • 18.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Africa Countries
  • 18.6. Africa Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 18.7. Africa Metabolic Disorders Drugs Market: Country Analysis
    • 18.7.1. Egypt Metabolic Disorders Drugs Market
      • 18.7.1.1. Egypt Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.2. Nigeria Metabolic Disorders Drugs Market
      • 18.7.2.1. Nigeria Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.3. South Africa Metabolic Disorders Drugs Market
      • 18.7.3.1. South Africa Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

19. Metabolic Disorders Drugs Market Competitive Landscape

  • 19.1. Competitive Market Overview
  • 19.2. Market Shares
  • 19.3. Company Profiles
    • 19.3.1. Sanofi S.A
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Company Metabolic Disorders Drugs Market Structure And Strategy
      • 19.3.1.3. Company Metabolic Disorders Drugs Market Products And Services
      • 19.3.1.4. Financial Performance
    • 19.3.2. Novo Nordisk A/S
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Company Metabolic Disorders Drugs Market Structure And Strategy
      • 19.3.2.3. Company Metabolic Disorders Drugs Market Products And Services
      • 19.3.2.4. Financial Performance
    • 19.3.3. AstraZeneca Plc
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Company Metabolic Disorders Drugs Market Structure And Strategy
      • 19.3.3.3. Company Metabolic Disorders Drugs Market Products And Services
      • 19.3.3.4. Financial Performance
    • 19.3.4. Johnson & Johnson
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Company Metabolic Disorders Drugs Market Structure And Strategy
      • 19.3.4.3. Company Metabolic Disorders Drugs Market Products And Services
      • 19.3.4.4. Financial Performance
    • 19.3.5. Merck & Co
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Company Metabolic Disorders Drugs Market Structure And Strategy
      • 19.3.5.3. Company Metabolic Disorders Drugs Market Products And Services
      • 19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Metabolic Disorders Drugs Market

21. Market Background: Pharmaceutical Drugs Market

  • 21.1. Pharmaceutical Drugs Market Characteristics
  • 21.2. Pharmaceutical Drugs Market Historic and Forecast, 2014 - 2022 Growth, by segment, Value ($ Billion), Global
  • 21.3. Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)
  • 21.4. Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 21.5. Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

22. Recommendations

  • 22.1. Global Metabolic Disorders Drugs Market In 2022- Growth Countries
  • 22.2. Global Metabolic Disorders Drugs Market In 2022- Growth Segments
  • 22.3. Global Metabolic Disorders Drugs Market In 2022- Growth Strategies

23. Appendix

  • 23.1. NAICS Definitions Of Industry Covered In This Report
  • 23.2. Abbreviations
  • 23.3. Currencies
  • 23.4. Research Inquiries
  • 23.5. The Business Research Company

24. Copyright And Disclaimer

Back to Top